Brii Biosciences Limited
BRIBF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $669 | $1,188 | $4,740 | $7,669 |
| - Cash | $1,003 | $490 | $1,191 | $2,855 |
| + Debt | $28 | $3 | $13 | $22 |
| Enterprise Value | -$307 | $702 | $3,563 | $4,836 |
| Revenue | $50 | $1 | $52 | $93 |
| % Growth | 7,993.4% | -98.8% | -44.2% | – |
| Gross Profit | $50 | $1 | $52 | $93 |
| % Margin | 100% | 100% | 100% | 100% |
| EBITDA | -$402 | -$168 | -$504 | -$603 |
| % Margin | -804.2% | -27,261.3% | -975.4% | -651.4% |
| Net Income | -$508 | -$175 | -$484 | -$4,120 |
| % Margin | -1,017.6% | -28,335.3% | -938.1% | -4,452.3% |
| EPS Diluted | -0.7 | -0.24 | -0.67 | -9.48 |
| % Growth | -191.7% | 64.2% | 92.9% | – |
| Operating Cash Flow | -$373 | -$594 | -$496 | -$879 |
| Capital Expenditures | -$3 | -$50 | -$139 | -$1 |
| Free Cash Flow | -$376 | -$644 | -$636 | -$880 |